Management of Mitral Valve Prolapse with Audible Clicks

Initial Diagnostic Approach

• The American College of Cardiology recommends performing echocardiography to confirm MVP, assess mitral regurgitation severity, evaluate leaflet morphology, and determine ventricular compensation in patients with physical signs of MVP, which is a Class I indication 1, 2
• The American Heart Association suggests that a midsystolic click is the hallmark auscultatory finding of MVP, representing sudden tensing of the mitral valve apparatus as leaflets prolapse into the left atrium during systole 1, 2, 3
• Dynamic auscultation can confirm the diagnosis, with the click moving earlier in systole when standing and later in systole when squatting 1, 2, 4
• A late systolic murmur may be present, which is medium-to-high pitched, loudest at apex, and occasionally has a musical or honking quality 1, 2, 3

Echocardiography Indications

• The American College of Cardiology recommends echocardiography for diagnosis and assessment of hemodynamic severity, leaflet morphology, and ventricular compensation in patients with physical signs of MVP, which is a Class I indication 1, 2, 5
• Echocardiography is also recommended for risk stratification in patients with physical signs of MVP or known MVP, which is a Class IIa indication 1, 2

Risk Stratification

• High-risk echocardiographic features that predict complications include leaflet thickness ≥5mm, which predicts endocarditis, need for mitral valve surgery, and complex ventricular arrhythmias 6, 5
• Moderate-to-severe mitral regurgitation is the strongest predictor of cardiovascular mortality and need for surgery 6
• Left ventricular internal diameter ≥60mm predicts the need for mitral valve replacement 6
• Leaflet redundancy with enlarged mitral annulus and elongated chordae is also a high-risk feature 1, 2, 5

Management Strategy

• The American College of Cardiology recommends reassuring patients with mild or no symptoms and milder forms of prolapse about the benign prognosis, and encouraging normal lifestyle and regular exercise 1, 2, 4, 5
• Aspirin 75-325mg daily is recommended for symptomatic patients with MVP who experience cerebral transient ischemic attacks, which is a Class I indication 3
• Warfarin is recommended for MVP with atrial fibrillation if age >65 OR hypertension OR MR murmur OR heart failure history, which is a Class I indication 1, 4, 7
• Aspirin 75-325mg daily is recommended for MVP with atrial fibrillation if age <65 AND no MR, hypertension, or heart failure, which is a Class I indication 1, 4, 7

Arrhythmia Evaluation

• ECG is often normal but may show nonspecific ST-T changes, T-wave inversions, prominent Q waves, or QT prolongation 1, 2, 5
• Ambulatory ECG monitoring or event monitors are useful for documenting arrhythmias in patients with palpitations, but are NOT indicated routinely in asymptomatic patients 1, 2, 5

Common Pitfalls to Avoid

• Do not rely solely on apical 4-chamber echocardiographic views, as there is disagreement about reliability of anterior leaflet billowing in this view alone; use parasternal long-axis views showing ≥2mm prolapse above the mitral annulus 1, 2, 5
• Do not overdiagnose MVP, as physical examination remains the optimal screening method; echocardiography without supportive clinical findings leads to false-positive diagnoses 9
• Do not attribute all symptoms to MVP, as controlled studies show true MVP syndrome consists of low body weight/blood pressure, minor skeletal abnormalities, orthostatic hypotension, and palpitations, but NOT atypical chest pain, dyspnea, or anxiety/panic attacks in isolation 1, 2